The role of melatonin treatment in chronic kidney disease.
The pineal hormone melatonin plays a major role in circadian sleep-wake rhythm. Patients with Chronic Kidney Disease (CKD), especially those who are on hemodialysis, frequently suffer from sleep disturbances. In this review an overview is given of the classification of stages of chronic kidney disease, followed by a presentation of the circadian rhythm disorders in renal disease involving sleep disturbances in relation to melatonin deficiency. The therapeutic benefit of melatonin treatment in sleep disorders related to chronic kidney disease including the controlled trials solving this topic, is described. Furthermore, the beneficial effect of melatonin on blood pressure alterations in CKD states and the protection of melatonin in oxidative stress and inflammation in renal disorders are explored. Finally a hypothetic model is described for the relation between circadian rhythm disorders and CKD.
Department of Hospital Pharmacy, Meander Medical Center, Amersfoort, The Netherlands.
Marije
M
Russcher
Birgit
B
Koch
Elsbeth
E
Nagtegaal
Karien
K
van der Putten
Piet
P
ter Wee
Carlo
C
Gaillard
D001794:Blood Pressure / Q000187:drug effects; D021081:Chronobiology Disorders / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D019454:Chronotherapy; D006801:Humans; D018836:Inflammation Mediators / Q000502:physiology; D007676:Kidney Failure, Chronic / Q000188:drug therapy / Q000503:physiopathology / Q000523:psychology; D008550:Melatonin / Q000502:physiology / Q000627:therapeutic use*; D008954:Models, Biological; D018384:Oxidative Stress / Q000187:drug effects; D006435:Renal Dialysis / Q000009:adverse effects; D051436:Renal Insufficiency, Chronic / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology; D012893:Sleep Wake Disorders / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D013315:Stress, Psychological
D018836:Inflammation Mediators; D008550:Melatonin